Current Neuro-Oncology
Volume
24 Number 11
15 June 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 11, 15 June
Ruggi
A, Melchionda F, Sardi I, Pavone R, Meneghello L, Kitanovski L,
Zaletel LZ, Farace P, Zucchelli M, Scagnet M, Toni F, Righetto R,
Cianchetti M, Prete A, Greto D, Cammelli S, Morganti AG, Rombi
B.
Toxicity
and Clinical Results after Proton Therapy for Pediatric
Medulloblastoma: A Multi-Centric Retrospective Study.
Cancers
(Basel). 2022 Jun 1;14(11):2747∟.
doi: 10.3390/cancers14112747∟.
PMID: 35681727∟.
Observational study. ˍ
Yang
C, Lan T, Wang Y, Huang WH, Li SM, Li J, Li FP, Li YR, Wang ZF, Li
ZQ.
Cumulative
Scoring Systems and Nomograms for Predicating Survival in Patients
With Glioblastomas: A Study Based on Peripheral Inflammatory
Markers.
Front
Oncol. 2022 Jun 1;12:716295∟.
doi: 10.3389/fonc.2022.716295∟.
PMID: 35719947∟.
Observational study. ˍ
Chen
X, Zhang Y, Zhao Q, Bai L, Chen X, Zhou Z.
Management
of dermatologic adverse events associated with tumor treating
fields in patients with glioblastoma multiforme: A 27-case
series.
Asia
Pac J Oncol Nurs. 2022 Jun 2;9(8):100095∟.
doi: 10.1016/j.apjon.2022.100095∟.
PMID: 36060271∟.
Observational study. ˍ
Gupta
T, Pervez S, Dasgupta A, Chatterjee A, Epari S, Chinnaswamy G,
Jalali R.
Omission
of upfront craniospinal irradiation in patients with low-risk
WNT-pathway medulloblastoma is associated with unacceptably high
risk of neuraxial failure.
Clin
Cancer Res. 2022 Jun 2, 2022:clincanres.0758.2022-3-10
10:06:35.290∟.
doi: 10.1158/1078-0432.CCR-22-0758? PMID: 35653134∟.
Observational study˰ ˍ
*
Duval
T, Lotterie JA, Lemarie A, Delmas C, Tensaouti F, Moyal EC,
Lubrano V.
Glioblastoma
Stem-like Cell Detection Using Perfusion and Diffusion
MRI.
Cancers
(Basel). 2022 Jun 4;14(11):2803∟.
doi: 10.3390/cancers14112803∟.
PMID: 35681782∟.
Interventional study. ˍ
Cucchiara
F, Luci G, Giannini N, Giorgi FS, Orlandi P, Banchi M, Di Paolo A,
Pasqualetti F, Danesi R, Bocci G.
Association
of plasma levetiracetam concentration, MGMT methylation and sex
with survival of chemoradiotherapy-treated glioblastoma
patients.
Pharmacol
Res. 2022 Jun 6;181:106290∟.
doi: 10.1016/j.phrs.2022.106290∟.
PMID: 35680010∟.
Observational study˰ ˍ
Satterlee
AB, Dunn DE, Valdivia A, Malawsky D, Buckley A, Gershon T, Floyd
S, Hingtgen S.
Spatiotemporal
analysis of induced neural stem cell therapy to overcome advanced
glioblastoma recurrence.
Mol
Ther Oncolytics. 2022 Jun 6;26:49-62∟.
doi: 10.1016/j.omto.2022.06.004∟.
PMID: 35784402∟.
Laboratory investigation. ˍ
Saraf
A, Yock TI, Niemierko A, Oh KS, Curry WT, Butler WE,
Arrillaga-Romany I, Ebb DH, Tarbell NJ, MacDonald S, Loeffler JS,
Shih HA.
Long-term
outcomes and late toxicity of adult medulloblastoma treated with
combined modality therapy: a contemporary single-institution
experience.
Neuro
Oncol. 2022 Jun 7, 2022:noac126∟.
doi: 10.1093/neuonc/noac126∟.
PMID: 35671386∟.
Observational study˰ ˍ
Baquero-Herrera
PE, Ardila-Martínez MA, Abdalá-Vargas NJ, Racedo J,
Ordóñez-Rubiano EG.
Treatment
Limitations for Pediatric Diffuse Intrinsic Pontine Gliomas in a
Middle-Income Country.
J
Neurosci Rural Pract. 2022 Jun 8;13(3):515-520∟.
doi: 10.1055/s-0042-1745714∟.
PMID: 35945995∟.
Observational study. ˍ
Berkman
JM, Nakhate V, Gonzalez Castro LN.
Glioblastoma
in Patients With Multiple Sclerosis.
Neurohospitalist.
2022 Jun 8;12(4):607-616∟.
doi: 10.1177/19418744221106003∟.
PMID: 36147751∟.
Case report˰ ˍ
Hu
XM, Nie XY, Xu KL, Wang Y, Tang F, Du ZG, Xiong J.
H3K27M
Mutation Doesn't Mean Worse Prognosis in Old Patients.
Front
Oncol. 2022 Jun 8;12:912166∟.
doi: 10.3389/fonc.2022.912166∟.
PMID: 35756637∟.
Observational study. ˍ
Karimaghaei
C, Pakravan M, Charoenkijkajorn C, Lee VA, Lee AG.
Visual
Loss as the Presenting Manifestation of Leptomeningeal Spread of
Glioblastoma Multiforme to the Optic Chiasm.
J
Neuroophthalmol. 2022 Jun 8∟.
doi: 10.1097/WNO.0000000000001632∟.
PMID: 36166776∟.
Case report˰ ˍ
Stoyanov
GS, Lyutfi E, Georgieva R, Dzhenkov DL, Petkova L, Ivanov BD,
Kaprelyan A, Ghenev P.
The
Role of Preoperative Neutrophil, Platelet, and Monocyte to
Lymphocyte Ratios as Independent Prognostic Factors for Patient
Survival in WHO 2021 Glioblastoma: A Single-Center Retrospective
Study.
Cureus.
2022 Jun 9;14(6):e25801∟.
doi: 10.7759/cureus.25801∟.
PMID: 35822134∟.
Observational study. ˍ
Zomer
A, Croci D, Kowal J, van Gurp L, Joyce JA.
Multimodal
imaging of the dynamic brain tumor microenvironment during
glioblastoma progression and in response to treatment.
iScience.
2022 Jun 9;25(7):104570∟.
doi: 10.1016/j.isci.2022.104570∟.
PMID: 35769877∟.
Laboratory investigation. ˍ
*
Cabezas-Camarero
S, García-Barberán V, Pérez-Alfayate R,
Casado-Fariñas I, Sloane H, Jones FS, Pérez-Segura
P.
Detection
of IDH1 Mutations in Plasma Using BEAMing Technology in Patients
with Gliomas.
Cancers
(Basel). 2022 Jun 11;14(12):2891∟.
doi: 10.3390/cancers14122891∟.
PMID: 35740557∟.
Observational
study.
ˍ
Jarmuzek
P, Kot M, Defort P, Stawicki J, Komorzycka J, Nowak K, Tylutka A,
Zembron-Lacny A.
Prognostic
Values of Combined Ratios of White Blood Cells in Glioblastoma: A
Retrospective Study.
J
Clin Med. 2022 Jun 13;11(12):3397∟.
doi: 10.3390/jcm11123397∟.
PMID: 35743468∟.
Observational study. ˍ
*
Maitre
M, Gupta T, Maitre P, Chatterjee A, Dasgupta A, Moiyadi A, Shetty
P, Epari S, Sahay A, Patil V, Krishnatry R, Sastri GJ, Jalali
R.
High-dose
salvage re-irradiation in recurrent/progressive adult diffuse
gliomas: development of a novel prognostic scoring system.
Cancer
Radiother. 2022 Jun 14, 2022:S1278-3218(22)00042-7∟.
doi: 10.1016/j.canrad.2022.01.004∟.
PMID: 35715356∟.
Observational study˰ ˍ
*
Ramos-Fresnedo
A, Domingo RA, Perez-Vega C, Pullen MW, Akinduro OO, Almeida JP,
Jentoft ME, Bendok BR, Chaichana KL, Trifiletti DM, Burns TC,
Porter AB, Kizilbash SH, Middlebrooks EH, Quiñones-Hinojosa
A, Sherman WJ.
The
early infiltrative phase of GBM hypothesis: are molecular
glioblastomas histological glioblastomas in the making? A
preliminary multicenter study.
J
Neurooncol. 2022 Jun 14∟.
doi: 10.1007/s11060-022-04040-5∟.
PMID: 35699848∟.
Observational study˰ ˍ
Drljača
J, Popović A, Bulajić D, Stilinović N, Vidičević
Novaković S, Sekulić S, Milenković I, Ninković
S, Ljubković M, Čapo I.
Diazepam
diminishes temozolomide efficacy in the treatment of U87
glioblastoma cell line.
CNS
Neurosci Ther. 2022 Jun 15∟.
doi: 10.1111/cns.13889∟.
PMID: 35703405∟.
Laboratory investigation. ˍ
Weller
J, Schäfer N, Schaub C, Potthoff AL, Steinbach JP, Schlegel
U, Sabel M, Hau P, Seidel C, Krex D, Goldbrunner R, Pietsch T,
Tzaridis T, Zeyen T, Borger V, Güresir E, Vatter H,
Herrlinger U, Schneider M.
Prognostic
impact of obesity in newly-diagnosed glioblastoma: a secondary
analysis of CeTeG/NOA-09 and GLARIUS.
J
Neurooncol. 2022 Jun 15∟.
doi: 10.1007/s11060-022-04046-z∟.
PMID: 35704157∟.
Observational study. ˍ